Revision total knee arthroplasty (TKA) for periprosthetic joint infection (PJI) is already a high-stakes endeavor. You’re managing infection, soft tissue compromise, bone loss, patient comorbidities — and now you’re also expected to perfectly thread the needle (sometimes literally) on venous thromboembolism (VTE) prophylaxis.
For years, many surgeons have defaulted to low-molecular-weight heparin (LMWH) in these complex cases. After all, if the patient is high risk, shouldn’t you go “stronger”?
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
